Khiron Begins Exports of Colombian Cannabis To Germany

2y
1m read
Summary

Colombian-Canadian cannabis firm Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), has announced the delivery of its first EU-GMP medical cannabis product to Germany. This represents a new revenue stream for Khiron and positions its European team to execute on its German medical strategy. We are excited to launch our portfolio with Khiron 1/14, a product that covers unmet medical need in the German market. We are already developing additional cannabis-based medicinal products from our certified strains recently imported from Colombia to improve access and product selection for German patients.” Source:  https://www.financecolombia.com/khiron-begins-exports-of-colombian-cannabis-to-germany/ Working with German firm Nimbus Health, Khiron products have been stocked in the Nimbus warehouse and are ready to be prescribed to patients via a network of 300 German pharmacies.

Article Preview

Colombian-Canadian cannabis firm Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), has announced the delivery of its first EU-GMP medical cannabis product to Germany. Working with German firm Nimbus Health, Khiron products have been stocked in the Nimbus warehouse and are ready to be prescribed to patients via a network of 300 German pharmacies.

This represents a new revenue stream for Khiron and positions its European team to execute on its German medical strategy. Leveraging Nimbus Health’s large distribution network and Khiron’s ongoing investments...

Read the full article @ Cannabis Law Report